Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains

Clinical and Vaccine Immunology

Volumn 14, Issue 3, 2007, Pages 234-238

  Borisova, Olga ^a   Kombarova, Svetlana Yu ^a   Zakharova, Nelli S ^c   Van Gent, Marjolein ^b   Aleshkin, Vladimir A ^a   Mazurova, Isabella ^a   Mooi, Frits R ^b  

^a GN Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology   (Russian Federation)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c MECHNIKOV RESEARCH INSTITUTE FOR VACCINES AND SERA   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; PERTUSSIS VACCINE;

ADOLESCENT; ALLELE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BORDETELLA PERTUSSIS; CHILD; CONTROLLED STUDY; GENE FREQUENCY; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PERTUSSIS; PRIORITY JOURNAL; RUSSIAN FEDERATION; SEROTYPE; VACCINE PRODUCTION;

EID: 34147179391     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00294-06     Document Type: Article

References (33)

1. Bass, J. W., and R. R. Wittler. 1994. Return of epidemic pertussis in the United States. Pediatr. Infect. Dis. J. 13:343-345.
2. Cassiday, P., G. Sanden, K. Heuvelman, F. Mooi, K. M. Bisgard, and T. Popovic. 2000. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J. Infect. Dis. 182:1402-1408.
3. Cherry, J. D., J. Gornbein, U. Heininger, and K. Stehr. 1998. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16:1901-1906.
4. Chistyakova, G. G., O. Borisova, I. N. Lytkina, I. K. Mazurova, Y. S. Komborova, A. S. Petrova, A. M. Memikova, and V. G. Skachkova. 2005. Specific features of the epidemic process of pertussis infection in Moscow. J. Microbiol. (Moscow) 5:35-40.
5. de Melker, H. E., J. F. Schellekens, S. E. Neppelenbroek, F. R. Mooi, H. C. Rumke, and M. A. Conyn-van Spaendonck. 2000. Reemergence of pertussis in the highly vaccinated population of The Netherlands: observations on surveillance data. Emerg. Infect. Dis. 6:348-357.
6. De Serres, G., N. Boulianne, F. M. Douville, and B. Duval. 1995. Pertussis in Quebec: ongoing epidemic since the late 1980s. Can. Commun. Dis. Rep. 21:45-48.
7. Fry, N. K., S. Neal, T. G. Harrison, E. Miller, R. Matthews, and R. C. George. 2001. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect. Immun. 69:5520-5528.
8. Gerasimova, A., M. S. Petrova, and N. T. Tikhonova. 2004. Clinico-epidemiological characteristic of the pertussis. Bull. Vaccine (Moscow) 5(35):4-5.
9. Guiso, N., C. Boursaux-Eude, C. Weber, S. Z. Hausman, H. Sato, M. Iwaki, K. Kamachi, T. Konda, and D. L. Burns. 2001. Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines. Vaccine 19:3248-3252.
10. Guris, D., P. M. Strebel, B. Bardenheier, M. Brennan, R. Tachdjian, E. Finch, M. Wharton, and J. R. Livengood. 1999. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin. Infect. Dis. 28:1230-1237.
11. Kanai, K. 1980. Japan's experience in pertussis epidemiology and vaccination in the past thirty years. Jpn. J. Med. Sci. Biol. 33:107-143.
12. Kourova, N., V. Caro, C. Weber, S. Thiberge, R. Chuprinina, G. Tseneva, and N. Guiso. 2003. Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains. J. Clin. Microbiol. 41:3706-3711.
13. Mastrantonio, P., P. Spigaglia, H. van Oirschot, H. G. van der Heide, K. Heuvelman, P. Stefanelli, and F. R. Mooi. 1999. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology 145(Pt 8):2069-2075.
14. Mazurova, I. K., O. I. Borisova, S. I. Kombarova, N. S. Zakharova, and V. A. Aleshkin. 2005. Molecular genetic characteristics of the B. pertussis strains isolated in different periods of the pertussis epidemic process. J. Mol. Genet. Microbiol. Virol. (Moscow) 4:21-25.
15. Miller, J. J., R. Silverberg, T. M. Saito, and J. B. Umber. 1943. An agglutinative reaction for Hemophilus pertussis. II. Its relation to clinical immunity. J. Pediatr. 22:644-651.
16. Mooi, F. R., H. Hallander, C. H. Wirsing von Konig, B. Hoet, and N. Guiso. 2000. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur. J. Clin. Microbiol. Infect. Dis. 19:174-181.
17. Mooi, F. R., Q. He, H. van Oirschot, and J. Mertsola. 1999. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect. Immun. 67:3133-3134.
18. Mooi, F. R., H. van Oirschot, K. Heuvelman, H. G. van der Heide, W. Gaastra, and R. J. Willems. 1998. Polymorphism in the Bordetella pertussis virulence factors P. 69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect. Immun. 66:670-675.
19. Muyldermans, G., D. Pierard, N. Hoebrekx, R. Advani, S. Van Amersfoorth, I. De Schutter, O. Soetens, L. Eeckhout, A. Malfroot, and S. Lauwers. 2004. Simple algorithm for identification of Bordetella pertussis pertactin gene variants. J. Clin. Microbiol. 42:1614-1619.
20. Packard, E. R., R. Parton, J. G. Coote, and N. K. Fry. 2004. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J. Med. Microbiol. 53:355-365.
21. Preston, N. W. 1985. Essential immunogens in human pertussis: the role of fimbriae. Dev. Biol. Stand. 61:137-141.
22. Robinson, A., A. R. Gorringe, S. G. Bunnell, and M. Fernandez. 1989. Serospecific protection of mice against intranasal infection with Bordetella pertussis. Vaccine 7:321-324.
23. Selezneva, T. T., and N. S. Titova. 2002. Influence of vaccination on the epidemic process of infections in Russia. J. Epidemiol. Infect. Dis. (Moscow) 2:6-11.
24. Semenov, B. F., N. S. Zakharova, and I. K. Mazurova. 2003. Increased pertussis morbidity in the background of mass vaccination. Hypotheses explaining this phenomenon. J. Microbiol. (Moscow) 6:70-73.
25. Sigaeva, L. A., R. G. Petrova, and R. G. Shakirova. 1990. Performance of epidemiological surveillance of whooping-cough, p. 95-102. In Epidemiological surveillance as a basis for prevention of intestine infections. Ministry of Health of Russia, Moscow, Russia.
26. Storsaeter, J., H. O. Hallander, L. Gustafsson, and P. Olin. 1998. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16:1907-1916.
27. Tsang, R. S., A. K. Lau, M. L. Sill, S. A. Halperin, P. Van Caeseele, F. Jamieson, and I. E. Martin. 2004. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J. Clin. Microbiol. 42:5364-5367.
28. Tsang, R. S., M. L. Sill, I. E. Martin, and F. Jamieson. 2005. Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine. Can. J. Microbiol. 51:887-892.
29. Tseneva, G., and N. Kourova. 2003. Microbiological characteristic of Bordetella pertusis and laboratory diagnosis. J. Clin. Microbiol. Antimicrob. Ther. 4:329-341.
30. van Amersfoorth, S. C., L. M. Schouls, H. G. van der Heide, A. Advani, H. O. Hallander, K. Bondeson, C. H. von Konig, M. Riffelmann, C. Vahrenholz, N. Guiso, V. Caro, E. Njamkepo, Q. He, J. Mertsola, and F. R. Mooi. 2005. Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J. Clin. Microbiol. 43:2837-2843.
31. van Loo, I. H., K. J. Heuvelman, A. J. King, and F. R. Mooi. 2002. Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J. Clin. Microbiol. 40:1994-2001.
32. van Loo, I. H., H. G. van der Heide, N. J. Nagelkerke, J. Verhoef, and F. R. Mooi. 1999. Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population. J. Infect. Dis. 179:915-923.
33. Weber, C., C. Boursaux-Eude, G. Coralie, V. Caro, and N. Guiso. 2001. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J. Clin. Microbiol. 39:4396-4403.